l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to The gut–brain axis and trimethylamine
The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Frontiers Impacts of intestinal microbiota metabolite trimethylamine N oxide on cardiovascular disease: a bibliometric analysis Meat metabolizing bacteria in atherosclerosis Nature Medicine A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





